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Abstract Translational cancer research requires integrative analysis of mul-
tiple levels of big cancer data to identify and treat cancer. In order to address
the issues that data is decentralised, growing and continually being updated,
and the content living or archiving on different information sources partially
overlaps creating redundancies as well as contradictions and inconsistencies,
we develop a data network model and technology for constructing and man-
aging big omic data. To support our data network approach for data process
and analysis, we employ a semantic content network approach and adopt the
CELAR cloud platform
The CELAR middleware functions can facilitate the management and ma-
nipulation of big omic data efficiently and cost-effectively by its automated
data provisioning mechanism and its dynamical elastic resource allocation
mechanism. The prototype implementation shows that the CELAR cloud can
satisfy the on-demanding needs of various data resources for management and
process of big cancer data.
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1 Introduction
Translational cancer research requires to integrate big cancer data, including
genomic, proteomic, and clinical information, to identify, prevent and treat
cancer [1,2]. This suggests scientists to incorporate multiple levels of biologi-
cal information within their studies such as phenotype, genotype, expression
profiling, proteomics, protein interaction, metabolic analysis and physiological
measurements, etc. [3,4].
We develop a new Cancer Data Network (CDN) model and the technology
for constructing and managing content in order to support the integration of
biological and clinical data with the research it is spawned from. In addition,
the CDN offers the ability of track several aspects of patient care according to
genetic and molecular profiles to facilitate tailoring of treatment.
In this paper, we propose the CDN architecture to stand as a novel con-
tent management model and associated system that supports end users in a
distributed, dynamic and evolving information landscape. The CDN architec-
ture shifts the view of content from being a static resource, and introduces
it as a dynamic and intelligent entity that is able to perform operations such
as linking itself to other relevant content. In doing so it can discover implied
relationships with other content, identifying redundancies and overlap as well
as updating its links with the ecosystem when new content is added or old
content is removed or depreciated.
The CDN approach is thus to enable the content itself as an active object
equipped with intelligence and semantic mechanisms that allow a greater de-
gree of flexibility towards automating the procedure of content management
and organization. To this end, we define active cancer data content as a logi-
cal container that contains the digital data content (i.e., patient data, clinical
data, research experiment data, publications, public gene or protein databases,
etc) together with intelligent and autonomic, self-organizing mechanisms for
automating content management.
Given that massive data is encoded into the CDN, it requires large amount
of data and computing resources to enable the manipulation of the data net-
work. We employ cloud computing platform to support the CDN approach.
Particularly the CELAR cloud platform [5,6] is selected as the CDN cloud
platform because CELAR delivers a fully automated and highly customisable
cloud platform for elastic provisioning of resources.
The remainder of this paper is organised as follows. Section 2 introduces
the principles and design of the CDN; Section 3 presents the architecture of the
CDN, focusing on its software components and the main interactions between
them, as well as how the components are instantiated for the implementation
with the CELAR cloud platform; Section 4 describes the related work; and
finally, Section 5 concludes the paper, and describes open issues and planned
future work.
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2 The Design of the CDN
The CDN is designed to bridge the gap between translational research and
targeted patient treatment. Hence, the design goals of the CDN are firstly to
better analyse data obtained dynamically from various bio-instrument sources
in order to answer biological question at a system level; and secondly to better
translate data obtained from in vitro and in vivo discoveries into the clinic.
2.1 Problems and Requirements
The key challenges that the CDN addresses is that information stored or pub-
lished over the web and other specialized data sources is decentralized, growing
and continually being updated. Furthermore, the contents stored or archived
on different information sources may partially overlap, thus creating redundan-
cies as well as contradictions and inconsistencies. In this section we describe
the current issues in the area of personalized medicine research.
2.1.1 Redundant or irrelevant information of protein and gene sequence
Currently, over a thousand accessible data sources provide information per-
taining to any gene, mRNA or protein sequence (estimated by the number
of known SRS “Sequence Retrieval System”) such as polymorphisms, protein
interactions and expression levels. The vast majority of the data sources are
specialised, maintained and updated by different organisations. In addition,
data sources with the same emphasis (such as nucleotide or protein sequences)
are updated and curated at different intervals and with various benchmarks
and standards. As a result, many databases contain outdated, redundant or
irrelevant information pertaining to the scientific questions at hand.
Also, our continually expanding knowledge base adds new dimensions to
the content. For example, the cataloging and assessment of functional impact
of recently discovered mechanisms of dynamic biological regulation (including
but not restricted to microRNAs and our knowledge of protein modification
types and permutations) is incomplete. New categorical discoveries and their
related information details need to be progressively built into any comprehen-
sive content structures.
2.1.2 Evolving methods of data generation from multiple instrument platforms
Translational cancer research requires the integration of data from state-of-
the-art technologies, for which the methods of translating and interpretation
raw instrument data into relevant contextualized biological outputs are contin-
ually improving. An example of this is the interpretation of mass spectrometry
peptide fragmentation data into qualitative and quantitative peptide and pro-
tein data in proteomics experiments. Different instruments produce data with
different technical characteristics, including signal-to-noise ratios, raw signal
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intensities, and data accuracy, precision and resolution. These characteristics
are continually changing for the better, but will continue to vary depending
on the type and generation of instruments used, new hardware innovations,
and the data acquisition and experiment style.
The bioinformatic translation of the raw fragmentation data into pep-
tide and protein identities is also evolving. Current strategies typically em-
ploy probabilistic, stochastic or descriptive models to pattern match fragment
ion profiles against theoretical profiles generated against assumed protein se-
quences and modification content. Personalised medicine will dictate a drift
away from this data interrogation strategy since each individual labours ge-
nomic and proteomic differences that would not be represented in an assumed
protein sequence database. This may involve fundamental changes to the data
interrogation strategy, for example, a migration towards de novo sequencing
tools, or at the very least changes to scoring of genepeptideprotein sequence
assignments and the specific identification of mutations, polymorphisms or
variables specific to individuals.
2.1.3 Creating genomic networks
To elucidate the wiring of cellular information processes, current research re-
quire integration of quantitative and dynamic data from several sources. Such
information sources could be genomic public database based, sequence-based
or clinical information and require various algorithms and software package
for data analysis. For maximal output from such data, it is important that
the multidimensionality is taken into account and the data can be visualised
with differential weighting of individual data sources. For example, gene muta-
tion and gene function interactions can be measured in a static manner using
techniques such as yeast 2 hybrid and complement assays as well as the dy-
namic and quantitative abundances can be included through platforms such as
COSMIC, VerScan and Meerkat runs. While each source provides important
information, the sources provide complementary aspects of information, which
is important to integrate and visualize.
To address the above issues, we design the CDN system to support:
1 Integrating heterogeneous and unstructured content. It allows sci-
entists to incorporate multiple levels of background information within
their studies, such as phenotype, genotype, expression profiling, proteomics,
protein-protein interactions, biochemical metabolic studies, and physiology
measurement, etc.
2 Decentralized control and collaborative communities. The content
itself either arises from biological experiments conducted by individual
groups or as a result of data integration and analysis studies using data
published by other groups.
3 Muilti-displine. The information is highly relevant to researchers work-
ing on other topics and it can be shared easily between specialized data
sources (including scientific literature) and databases focusing on specific
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topics, e.g. organisms, diseases, genes, proteins, metabolic pathways, chem-
ical compounds or on relationships between them.
Our special focus is addressing the issues of overwhelming and continuous
flood of complex information generated and published on a daily basis through
the use of semantic web technology. We illustrate our approach in the next
section.
2.2 Semantic Approach
The CDN aims to develop novel mechanisms for constructing and generat-
ing symbiotic, semantically-described cancer data network that enables dis-
tributed heterogeneous cancer data to be linked together into data networks
for integrative data analysis.
2.2.1 The Cancer Data Networks
A key feature of cancer information is that it is continually evolving. For ex-
ample, new information about a particular cancer entities (e.g. proteins, genes
or diseases) is being published on a daily basis. Furthermore, the decentralized
authority over the content, whereby scientists in different organizations pub-
lish and manage their own findings, means that information about the same,
similar or related entities, may be stored on different sources that evolve in
different ways. This inevitably results in partial overlaps in the coverage of the
data sources creating redundancies as well as contradictions and inconsisten-
cies at both the entity and the concept level.
We design the CDN to link individual elements of the digital content to-
gether. By using semantic data model and ontology, we define two type of links
among the CDN nodes (i.e. content): explicit links and conceptual links.
Explicit links between different elements are typically stored with the con-
tent. At the simplest level a entry on a specific protein on a particular data
source can make explicit references to other protein, gene or disease entries
on other sources, or to specific supporting scientific publications. Ontologies
can be used to either manually or automatically assign scientific papers, genes,
proteins, to different categories.
Conceptual links between different elements are typically not stored with
the content, but they can traditionally be inferred by using either statisti-
cal/probabilistic analysis techniques or domain knowledge. At the simplest
level, users may wish to group proteins together based on the similarity of
specific properties such as their effect on the same cellular function, or their
causal implication to a similar disease phenotype.
The two types of links can represent all kinds of relationships among cancer
contents (e.g., concepts and instances). And they are used to connect various
cancer entities into a cancer data network.
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2.2.2 Retrieval, Integration and Update
In [7], we developed a semantic information integration approach to integrate
and update information from distributed, heterogeneous data sources dynam-
ically. The CDN employs ActOn [8,7] as a means to retrieve, integrate, and
manage the CDN Content in a intelligent and active manner.
The ActOn is an ontology-based information integration approach that is
suitable for highly dynamic distributed resources. To deal with the issue that
information changes frequently and information requests have to be answered
quickly in order to provide up-to-date information, the ActOn employs an
information cache that works with an update-on-demand policy. Due to the
multitude of databases and information sources, the most appropriate sources
have to be selected for each query to ensure optimal and relevant data retrieval.
To deal with this issue that the most suitable information sources have to be
selected from a set of different distributed information sources that can pro-
vide the information needed, the ActOn adds an information source selection
step to the ontology-based information integration. Thereby, the most suitable
information sourcedatabase will be selected for a user query.
2.3 CDN Architecture
Figure 1 shows three-tier view of the CDN architecture. At the core of the
middleware lies the CDN ActOn Information Manager that represents the
cancer data content and its associated information extraction tools. The CDN
ActOn contains the semantic metadata and knowledge management tools that
enable modelling and analyzing its life cycle and support reasoning about the
content. The CDN also contains the workflow tools (Workflow engine) that
enable the statistical analysis of the content enabling it to self-organise when
linking with other contents. Finally, the CDN also includes semantic-aware
and peer-to-peer based networking functionality that enables the content to
discover other contents and communicate with them.
2.3.1 System Components
We use a bottom-up description of the components shown in Figure 1.
The CDN semantic model The bottom layer represents existing and
traditional data sources that will be used within CDN. Digital content elements
on the sources will be identified and extracted and represented as Knowledge
Cells (KC) that represent the core of an data content object and represent
nodes in abstract CDN. Semantic reasoners can be employed to infer logical
consequences from a set of asserted facts of those KCs, so that KCs are able
to self-manage and self-organise. Data sources can be accessed through the
middleware and offered to the application platform.
The ActOn Information Manager The CDN middleware employs the
ActOn, a semantic information integration system, to connect the data sources
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to the CDN system. The ActOn Information Manager can deploy the Data
content and place it inside the CDN which contains extra information about
the content that makes it both self-aware and context-aware together. The
ActOn Information Manager can also link the data content in multiple data
content networks. During system operation, the links (the edges in the net-
work graph shown in Figure1) between data content entities (the nodes in the
network graph in Figure1 can be re-organized based on statistical analysis,
user preferences or other types of runtime information.
Workflow engine The Workflow engine enables data document access
over preprocessing, tokenization, parsing, named entity recognition to the final
consumer. It implements specialized workflows that support the different types
of users of the system (publishers, curators and end users) in combining data
retrieval, integration, semantic annotation and deployment of data content
within data analysis tasks in end user applications. The starting point for
implementing the workflow engine is to employ Tarverna workflow system
(authoring tools and execution engines) for the integration and analysis of a
wide variety cancer data (including genomic, proteomic data sets, as well as
free text publications).
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KC	  
KC	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KC	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  Paper	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CELAR Cloud Platform 
CDN 
        ActOn IM 
(semantic metadata) 
        User GUI Interface 
           (web interface)
  
     Workflow Engine 
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Fig. 1 Overview of the CDN Architecture
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Semantic Web User Interface At the top-level, a user interface in-
cludes functions that can be used to connect to the CDN middleware so that
contents can be retrieved from the distributed data sources (shown as differ-
ent databases in the bottom of Figure 1) to create the relevant data content.
When a data content is created, it is passed to the CDN middleware and then
added in the CDNs. The user interface can also interact with the user, issue
user-queries and get back results which the CDN present to the users in an
advanced way, showing the KCs inside the retrieved content. As such, the user
can use the KC to issue/refine further queries or even browse based on a given
KC in order to find similar KCs and iteratively refine his queries within the
CDN to get satisfactory results.
3 A Cloud Platform for CDN
In order to assess whether the genome can tell us more about the undue bur-
den, the CDN needs to manage and process large amount of genomic and
proteomic data to identify the driven mutation of tumor samples, and then
to associate the identified mutation with protein functions within a cell signal
network. Given 3 billion DNA base pairs of human genome and 25,000 hu-
man protein-code genes, the CDN actually requires massive, various data and
computing resources as well as associated software environments. This implies
that the elasticity of cloud computing [9–11] can play a key role for the CDN
approach. Taking advantages of cloud computing, the CDN can be supported
in a way that continually involved massive data will always get enough data
resources dynamically and seamlessly for its needs.
3.1 The Selection of CELAR Cloud Platform
The EU CELAR platform is a fully automated and highly customisable
system for elastic provisioning of resources in cloud computing platforms (Fig-
ure 2). The CELAR aims at providing an elasticity layer for applications that
need to take advantage of the elastic, pay-as-you-go resource provisioning na-
ture of cloud infrastructures in a transparent and customizable manner. There-
fore it is a suitable cloud platform for managing and manipulating big omic
data of the CDN. More precisely, the CELAR is able to allocate the data and
computing resources to the CDN according to the size of its genome data and
the data processes needed. In this section, we introduce the CELAR platform
and describe how the CELAR platform manages data elasticity in the CDN
level to analyze large scale cancer data efficiently and economically.
We design the CDN as a data network module that can run on top of the
CELAR cloud platform. In particular, we allow the CDN can support compu-
tational and data elasticity so that the CELAR can intelligently orchestrate
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Fig. 2 The CELAR Cloud Platform
and adjust the computing resource allocation according to needs of cancer
diagnose and the nature of cancer data of individual patients.
3.2 CELAR Middleware for CDN
The CELAR enhances the functionality provided by current cloud infrastruc-
tures and provide automated, multi-grained, elastic resource provisioning for
cloud-based applications, such as the CDN. In this section, we explain how
the CDN can co-operate with the CELAR middleware components.
As shown in Figure 2, the application management modules will be devel-
oped and provided under the c-Eclipse framework and exposed via meaningful,
user-friendly UIs to the end-users and application experts. The CDN will in-
teract with the application management modules to control the CDN data
network accordingly. The modules enable intelligent, application- and user-
aware description and the deployment of the CDN. It can also monitor the
changes of the CDN, exposing an overview of the current and past status of
the CDN processes as well as the available resources (software and hardware)
from the underlying Infrastructure as a Service (IaaS).
The CDN Data can be stored in plain files and accessed through data
wrappers or via database systems that range from typical relational databases
to NoSQL stores. The provisioning layer consists of well-known database sys-
tems that can be described and profiled by the CELAR platform. Some of
these systems, such as the distributed NoSQL stores, exhibit horizontal elastic
behavior that can be exploited by the CELAR platform; others, such as cen-
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tralized RDBMS, exhibit vertical resizing functionality based on the resources
dedicated on a single virtual machine.
Similar to the storage resource, the CDN uses the CELAR Provisioner to
prepare largest amount of computing resources used for the CDN and needs
to be elastically scaled. To do so, the CDN will provide application-lever in-
formation that can be used to predict the computing resources required in the
CDN operation. Apart from dynamic provisioning of computing resources, the
CELAR can also be used to provide online resizing of the resources allocated
to the CDN when the involved data is removed or added.
3.3 CDN Data processed by CELAR SCAN
SCAN [12] as a CELAR application platform can be applied to support data
analyses on top of the CDN. The key objective of SCAN application platform
is to match the resource demand required by a variety of bio-applications
or by different volume of cancer data. SCAN is comprised of a number of
genomic and/or proteomic applications, which may incorporate multiple levels
of biological information of a CDN within studies such as phenotype, genotype,
expression profiling, proteomics, protein interaction, metabolic analysis and
physiological measurements, etc.
The SCAN processes CDN data with cloud resources. With different re-
quests and stages of process, the SCAN can talk to the CELAR middleware
to obtain substantially different levels and types of resource ideally suited.
For example, mapping of deep sequencing data to genome annotation via a
relational database such as ENS-EMBL [13] relies on the ability to perform
frequent joins across multiple tables containing millions of rows, while com-
putation of downstream statistics is often dependent on repeated numerical
calculations over permuted data in order to provide a null distribution. Also
SCAN may help CDN to have different resource needs due to the size and com-
plexity of the data of CDN. For example, SCAN mutation detection process
can take 4 CPU/hours for Whole Exome Sequencing data in the CDN network
or 10 CPU/hours for whole genome sequencing (WGS) data of CDN network.
In general, SCAN can help to process more than thirty kinds of genome data of
CDN, which can be used for cancer research, such as Whole Exome Sequenc-
ing data, Whole Genome Sequencing data, total RNA data, miRNA sequence
data etc.
3.4 Implementation
We implement the CDN system using Java Spring Framework and RDF Jena
API. Spring is a software toolkit that can be used to program web-based
application and data management system. Jena is a Java API that can be used
to create and manipulate RDF models. Using Spring framework, we are enable
to code the system in Java following the WSRF specification. We use Jena
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Fig. 3 An example of CDN network.
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OWL toolkit for creating, manipulating and querying the semantic metadata
of data content.
In view of the large volume of the cancer data, we use the CELAR cloud
platform, a elastic cloud computing platform, to process and build the CDN
system. The EU CELAR cloud can deliver a fully automated and highly cus-
tomisable system for elastic provisioning of resources within cloud comput-
ing infrastructures. It therefore can provide large scale computation resources
required by the CDN. In addition the CELAR platform can also provision
particular types of computing resources required by the CDN dynamically,
such as windows system with large memory or large amount CPU resources
of linux systems, etc. Currently our prototype implementation is mainly for
creating and managing gene mutation data and the next generation sequenc-
ing variation detection data. We have processed about 10TB whole genome
sequence data and linked them with Uniprot protein database to generate the
sample-protein-gene network in Figure 3. The initial results shows that data
within CDN can be linked based on domain ontology. As shown in Figure 3,
the big cancer data processing can be executed efficiently without delay since
relevant data are already be retrieved into the CDN. For example, the retrieval
of information about DRSC gene to PyK protein in the CDN. Also the link
between Tamoxifen10 to PyruvateKinase is identified automatically by CDN
without manually search.
4 Related Work
In the life sciences area there are several systems available that add seman-
tic annotations, primarily these are done through Medline or similar litera-
ture databases. Some examples include iHop2, WhatIzIt3 and EBIMed4, and
BioAlma5 [14–16]. Entities (such as gene names, protein names, drug names)
are recognised and links are added, however, a disadvantage is that the recog-
nition is not active, it is done once, off-line, and is not active in the CDN
sense. Since the semantic framework to recognize entity identity across differ-
ent services is currently missing, these services all point to a small subset of
the data that is available for these entities, i.e. these systems are like isolated
silos, compared to the CDN’s model of self-organizing, distributed structure.
Adding semantic markups to more structured data is a relatively new area
that has not been systematically addressed in the biosciences. Such a system
would take protein sequence files, or entire EMBL databases [17] to search
against. It then would add database cross-reference information, and also add
semantic annotations statically [18,19], similar as the iHop [16].
Most cloud platforms focus on on-demand (elastic) provisioning that allows
for better performance for the customers [20–22]. However, it is difficult for
a user to figure out the proper scaling conditions based on input data of an
application, especially when the CDN is executed on a third-party virtualized
cloud computing infrastructure. Furthermore, client needs change dynamically,
requiring different optimizations relative to the amount of reserved resources.
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Most cloud platforms are proprietary services that run on dedicated servers,
translating to lack of elasticity due to vendor lock-in and questionable perfor-
mance. The works in [23] solve the problem of optimizing the resources of each
virtual machine (CPU, memory, etc) to achieve maximum performance, while
the work in [24] mainly target at energy efficient cloud solution. We need a
fully automated and highly customizable cloud platform that performs elastic
resource provisioning to various data networks [6,25].
5 Conclusion
In this paper we present the CDN, an active content management system for
personalized medicine research. The CDN is based on a semantic content net-
work approach which overcomes some of the limitations of current content
management approaches when dealing with dynamic, distributed and redun-
dant bio-data sources.
Our main contribution over the state of the art in content management
systems is that we propose the CDN architecture supporting deployment of
the CDN, defining the containers and the networking capabilities that allow
remote interactions between data content entities. We also develop a CDN
prototype system as a cloud-based, networking middleware for cancer data
content discovery and communication.
The initial results show the CDN can facilitate both the cataloguing of
samples collected during routine research and the management of datasets
generated by numerous multi-step experiments carried out from a single sam-
ple. For example, the CDN can provide a platform whereby all tissue samples,
experimental step samples, datasets and analysis can be compiled and linked
allowing ease of access to every stage in a open manner in order to streamline
research, immortalise and protect scientific data and increase productivity.
In the future, we intend to apply real patient data and evaluate perfor-
mance of the CDN. We also plan to adopt new network algorithms to guide
the data integration, and enhance the interaction between CDN and Cloud
middleware.
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